Unidentified microbiological contamination of the active substance (gentamicin sulfate) was detected, posing a real and direct risk to patients and potentially adversely affecting the efficacy and safety of use of the eye ointment. Potential effects: eye infections, infectious complications, reduced treatment effectiveness.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use ointment from batches 153 and 243. Check the batch number on the packaging and, if you have these batches, return the product to a pharmacy or contact a doctor or pharmacist.
The Chief Pharmaceutical Inspector withdrew Dexamytrex batches 153 and 243 from the Polish market and prohibited their further marketing, granting the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related